Depression-associated gut microbes, metabolites and clinical trials
Frontiers in Microbiology · 31.01.2024 · 15
DOI: 10.3389/fmicb.2024.1292004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 31.01.2024. Verfasst von Meiling Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, School of Medical Technology and Engineering, Fujian Medical Universit…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
Depression is one of the most prevalent mental disorders today. Over the past decade, there has been considerable attention given to the field of gut microbiota associated with depression. A substantial body of research indicates a bidirectional communication pathway between gut microbiota and the brain. In this review, we extensively detail the correlation between gut microbiota, including Lactobacillus acidophilus and Bifidobacterium longum , and metabolites such as short-chain fatty acids (SCFAs) and 5-hydroxytryptamine (5-HT) concerning depression. Furthermore, we delve into the potential health benefits of microbiome-targeted therapies, encompassing probiotics, prebiotics, and synbiotics, in alleviating depression. Lastly, we underscore the importance of employing a constraint-based modeling framework in the era of systems medicine to contextualize metabolomic measurements and integrate multi-omics data. This approach can offer valuable insights into the complex metabolic host-microbiota interactions, enabling personalized recommendations for potential biomarkers, novel drugs, and treatments for depression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.
- Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China.
- Genomic Medicine Institute, Lerner Research Institute, Cleveland, OH, United States.
- Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, M., Song, Z., Lai, S., Tang, F., Dou, L., & Yang, F. (2024). Depression-associated gut microbes, metabolites and clinical trials. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1292004
Vancouver
Wang M, Song Z, Lai S, Tang F, Dou L, Yang F. Depression-associated gut microbes, metabolites and clinical trials. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1292004
BibTeX
@article{Wang2024,
author = {Wang, Meiling and Song, Zhaoqi and Lai, Shirong and Tang, Furong and Dou, Lijun and Yang, Fenglong},
title = {Depression-associated gut microbes, metabolites and clinical trials},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1292004}
}
EUVIMED